Results 61 to 70 of about 73,286 (248)

Bacterial Vaginosis and Vulvovaginal Candidiasis Pathophysiologic Interrelationship

Microorganisms
Among the infectious causes of vulvovaginal symptoms, bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC) dominate. Apart from infrequent mixed infections, both are considered independent and caused by unrelated pathogenic mechanisms.
J. Sobel, Yogitha Sai Vempati
semanticscholar   +1 more source

Role of Vaginal Mucosa, Host Immunity and Microbiota in Vulvovaginal Candidiasis

Pathogens, 2022
Vulvovaginal candidiasis (VVC) is a prevalent gynaecological disease characterised by vaginal wall inflammation that is caused by Candida species. VVC impacts almost three-quarters of all women throughout their reproductive years.
S. Balakrishnan, Haizat Yamang, M. Lorenz, Shu-Yih Chew, L. Than   +4 more
semanticscholar   +1 more source

Urogenital Infection Risk Associated With SGLT2 Inhibitors Versus DPP‐4 Inhibitors in Type 2 Diabetes and Chronic Kidney Disease: A Nationwide Target Trial Emulation

Clinical Pharmacology &Therapeutics, EarlyView.
Although sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) are recommended for patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD), concerns regarding urogenital infections persist. Therefore, we evaluated the risk of urinary tract infection (UTI) and genital tract infection (GTI) after SGLT2i initiation in this population ...
Young‐Mi Ah, Junsung Nam, Jung Wook Youn, Yun Mi Yu, Soyoung Kang   +4 more
wiley   +1 more source

Inflammatory cytokine signalling in vulvovaginal candidiasis: a hot mess driving immunopathology

Oxford Open Immunology
Protective immunity to opportunistic fungal infections consists of tightly regulated innate and adaptive immune responses that clear the infection. Immune responses to infections of the vaginal mucosa by Candida species are, however, an exception. In the
K. Cheng, Dolly E. Montaño, T. Zelante, Axel Dietschmann, M. Gresnigt   +4 more
semanticscholar   +1 more source

Inflammatory invasion on human vaginal mucosa correlated with combined drug treatment and recurrence in recurrent vulvovaginal candidiasis

The journal of obstetrics and gynaecology research, 2023
Recurrent vulvovaginal candidiasis (RVVC) is a chronic, difficult to treat vaginal infection, caused by Candida species, which affects women of all ages and ethnic and social background.
Xinyi He, Qiong-Lan Tang, Feng-Shu Zhan, Yiwen Mao, Fei Ye, Ze-Ping Weng, Xuefeng Jiang, A. Swidsinski   +7 more
semanticscholar   +1 more source

Interactions between lactobacillus and yeast: A recent update

Food Biomacromolecules, EarlyView.
Abstract Lactobacillus and yeast are microorganisms widely distributed in nature. Their interactions significantly impact fermentation processes, human health, and medical care. However, there is a lack of a systematic summary of the characteristics of these interactions, and the mechanisms underlying these interactions remain unclear.
Yang Chen, Mengyuan Liu, Mengchen Li, Zhiyun Yue, Yang Mu, Chao Wang, Lusha Xia, Junjun Gao, Mingye Peng, Ran Wang, Mengzhou Zhou   +10 more
wiley   +1 more source

Assessment and management of dyspareunia in peri‐ and postmenopausal women: A phenotype‐based gynecologic approach

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Dyspareunia in peri‐ and postmenopausal women is common, clinically consequential, and often undertreated in gynecologic practice. Although genitourinary syndrome of menopause (GSM) is a frequent contributor, intercourse‐related pain may also reflect vestibular, pelvic floor, dermatologic, inflammatory, treatment‐related, and psychosocial ...
Marek Broul, Marcel Vančo, Jaroslava Banýrová, Aneta Hujová   +3 more
wiley   +1 more source

Comparison of Single Dose Sertaconazole versus Three Dose Clotrimazole Regime in Treatment of Uncomplicated Vulvovaginal Candidiasis- A Prospective Study [PDF]

Journal of Clinical and Diagnostic Research, 2019
Introduction: Vulvovaginal candidiasis is the second most common vaginitis following bacterial vaginitis amongst the reproductive age group with variable compliance to the treatment.
Katha Desai, Pradip Sambarey
doaj   +1 more source

Vaginal microbiota: Potential targets for vulvovaginal candidiasis infection

Heliyon
Vulvovaginal candidiasis (VVC) is the second most common cause of vaginal infection globally after bacterial vaginosis (BV) and associated with adverse reproductive and obstetric outcomes, including preterm delivery, sexually transmitted infections and ...
Yu-Fei Wang, Zhao-Xia Liu, Ting-Tao Chen
semanticscholar   +1 more source

“Efficacy and safety of oteseconazole in recurrent vulvovaginal candidiasis (RVVC) – A systematic review and meta-analysis"

Heliyon, 2023
Background Recurrent Vulvovaginal Candidiasis (RVVC) is defined as 3 or more episodes of symptomatic Vulvovaginal Candidiasis (VVC) within a year. Out of 75 % of women with VVC, this debilitating infection is experienced by 9 % of women.
Tasmiyah Siddiqui, Kanwal Ashok Kumar, Amna Iqbal, Payal Rani Doultani, Tayyaba Ashraf, Farea Eqbal, Samrah Inam Siddiqui   +6 more
semanticscholar   +1 more source